Stay updated on Durvalumab After Radiation in Stage 3 NSCLC – Clinical Trial

Sign up to get notified when there's something new on the Durvalumab After Radiation in Stage 3 NSCLC – Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab After Radiation in Stage 3 NSCLC – Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Record history now lists Revision: v3.6.3, replacing the previous Revision: v3.6.2 in the version entries. This reflects an update to the history metadata on the page.
    Difference
    0.1%
    Check dated 2026-07-04T08:11:04.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A new page revision entry (v3.6.2) was added to the Record History, replacing the previous (v3.6.0). This update reflects a version change in the page rather than a change to study data or results.
    Difference
    0.1%
    Check dated 2026-06-27T04:14:05.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The study record now indicates recruitment is closed (no longer looking for participants), and the history shows a new revision (v3.6.0) added with the previous revision (v3.5.5) removed.
    Difference
    0.3%
    Check dated 2026-06-12T23:44:00.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.5.5 to the history and removed Revision: v3.5.4 from the record.
    Difference
    0.1%
    Check dated 2026-06-05T17:13:18.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    A new history entry for revision v3.5.4 has been added to the Study Record Versions list, while v3.5.3 was removed, updating the sequence of record revisions.
    Difference
    0.1%
    Check dated 2026-05-15T06:00:25.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    The page’s displayed revision/version number was updated from v3.5.2 to v3.5.3, reflecting a change to the site’s revision label without altering the underlying study record content.
    Difference
    0.1%
    Check dated 2026-04-24T05:48:18.000Z thumbnail image

Stay in the know with updates to Durvalumab After Radiation in Stage 3 NSCLC – Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab After Radiation in Stage 3 NSCLC – Clinical Trial page.